News Article
Chemours Commends the European Patent Office for Upholding Solstice’s HFO-1234yf Process Patent
The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company, applauds the decision by the Boards of Appeal of the European Patent Office to uphold European Patent EP 2546225, which protects HFO‑1234yf manufacturing processes.
Read More
Press Release
Following Successful Fluid Qualification Chemours & 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers & IT Equipment
Published February 24, 2026
The Chemours Company (NYSE: CC), a global chemistry company, and 2CRSi (ISIN code: FR0013341781), a pioneer in high-performance, eco-responsible server technology, today announced a Joint Development Agreement (JDA) following the successful qualification of Chemours’ Opteon™ two-phase immersion cooling fluid in current-generation 2CRSi servers.
Read More
Press Release
The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
Published February 19, 2026
The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2025.
Read More